SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Rafael S,Martinez ^[1] ; Mark J,Salji ^[2] ; Linda,Rushworth ^[1] ; Chara,Ntala ^[2] ; Giovanny,Rodriguez Blanco ^[1] ; Ann,Hedley ^[2] ; William,Clark ^[1] ; Paul,Peixoto ^[2] ; Eric,Hervouet ^[1] ; Elodie,Renaude ^[1] ; Sonia H Y,Kung ^[1] ; Laura C A,Galbraith ^[3] ; Colin,Nixon ^[4] ; Sergio,Lilla ^[3] ; Gillian M,MacKay ^[4] ; Ladan,Fazli ^[3] ; Luke,Gaughan ^[4] ; David,Sumpton ^[5] ; Martin E,Gleave ^[6] ; Sara,Zanivan ^[1] ; Arnaud,Blomme ^[2] ; Hing Y,Leung ^[1]

作者单位： CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom. ^[1] Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, United Kingdom. ^[2] Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France. ^[3] EPIGENExp, (EPIgenetics and GENe EXPression Technical Platform), Besançon, France. ^[4] Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. ^[5] Vancouver Prostate Centre, Vancouver, British Columbia, Canada. ^[6] Northern Institute for Cancer Research, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom. ^[7] CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom. h.leung@beatson.gla.ac.uk a.blomme@uliege.be. ^[8]